Swiss Nordic Bio Zürich 30 mars 2023
Reference number | |
Coordinator | BrainSafe AB |
Funding from Vinnova | SEK 8 200 |
Project duration | March 2023 - March 2023 |
Status | Completed |
Venture | 2023-00007-en |
Important results from the project
** Denna text är maskinöversatt ** Aim and goal is to identify potential partners and investors who can help finance the company´s continued growth and expansion. By networking and presenting its activities at the conference, Brainsafe can also receive feedback from experts in the industry, which can help the company strengthen its position and develop new products and services. By attending the conference, Brainsafe can also improve its knowledge of industry trends and innovations, which can help the company adapt its strategy and remain competitive in the market.
Expected long term effects
** Denna text är maskinöversatt ** The goal of participating in Swiss Nordic Bio was to increase Brainsafe´s visibility, build relationships, identify partners and investors to finance the company´s growth. They attended presentations and exhibitions, networked and met investors. After the conference, they established several contacts that led to new partnerships and investments. Industry trends and innovations gave them insights to adapt the strategy and develop new products and services.
Approach and implementation
** Denna text är maskinöversatt ** Swiss Nordic Bio-projektet aimed to increase Brainsafe´s visibility and build relationships within the biotechnology and pharmaceutical industry. They participated in presentations, discussions and exhibitions to increase brand awareness and identify partners and investors. The project led to several new collaborations and partnerships and gave Brainsafe unique insight into industry trends and innovations.